Clinical Trials Logo

Retinoblastoma clinical trials

View clinical trials related to Retinoblastoma.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02955524 Withdrawn - Clinical trials for Hemodynamic Instability

Topical Anesthesia and Intra-arterial Chemotherapy for Retinoblastoma

TOPIAC
Start date: March 2018
Phase: Early Phase 1
Study type: Interventional

The objective of this study is to use local topical anesthesia to numb the sensory input, captured by branches of the Trigeminal nerve found on the skin in and around the eye, to decrease a hemodynamic reflex seen during placement of a catheter for intra-arterial chemotherapy (IAC) for eye tumors in children. This Trigeminal-cardiac reflex brings about hemodynamic instability during general anesthesia. Normally, one could block this sensorial input with ophthalmic peribulbar placement of local anesthetics, but these eyes have malignant growth and invasive procedures may cause more harm. The investigators are aiming to numb the sensory branches of the trigeminal nerve non-invasively and observe for any decrease in these events.

NCT ID: NCT02655432 Withdrawn - Cataract Clinical Trials

Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population

POPH
Start date: January 2016
Phase: Phase 0
Study type: Observational

Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener. The photoscreener results will be compared to the complete ophthalmologic evaluation. Primarily, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Secondarily, this study will gather epidemiological information on vision problems in the haitian children population.

NCT ID: NCT01151748 Withdrawn - Retinoblastoma Clinical Trials

Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma

Start date: September 2010
Phase: Phase 2
Study type: Interventional

Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma

NCT ID: NCT00980551 Withdrawn - Retinoblastoma Clinical Trials

Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma

RELRB1
Start date: May 2010
Phase: N/A
Study type: Interventional

The investigators are testing subtenon carboplatin in combination with vincristine and topotecan given by vein in the hopes of finding a drug combination that may be effective against retinoblastoma that has come back (recurrent) or is resistant to other treatment (refractory). The goals of this study are: - To decide if the drug combination is a useful treatment for recurrent or refractory retinoblastoma - To test the safety of the drug combination and to see what kind of effects (good and bad) can be expected from the drug combination - To measure visual changes before and after the study therapy - To use a special MRI scan to measure brain function involved in vision processing, both before and after the study therapy In this study, the investigators are also testing a new experimental way of giving carboplatin "subtenon carboplatin". The carboplatin will be given directly in the eye through a needle placed under the covering of the eye. This is to try to get more carboplatin to the retinoblastoma inside the eye.

NCT ID: NCT00003273 Withdrawn - Sarcoma Clinical Trials

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Start date: November 1997
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of different regimens of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed brain tumor.